Tocilizumab for Neuromyelitis Optica Spectrum Disorder: CADTH Health Technology Review [Internet]

Review
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Mar. Report No.: RC1477.
No abstract available

Publication types

  • Review